Anti-respiratory syncytial virus monoclonal antibodies show promise in the treatment and prophylaxis of viral disease.
Taylor
G
G
Institute for Animal Health, Compton, Berkshire, U.K.
Porter
T
T
Dillon
S
S
Trill
J
J
Ganguly
S
S
Hart
T
T
Davis
C
C
Wyde
P
P
Tempest
P
P
Harris
W
W
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D005818:Genetic Engineering; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology / Q000627:therapeutic use; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy*; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D012449:Safety
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D016756:Immunoglobulins, Intravenous